Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.14 - $12.49 $740 - $66,047
5,288 Added 0.92%
578,727 $88,000
Q3 2022

Nov 14, 2022

SELL
$8.51 - $13.6 $284,693 - $454,974
-33,454 Reduced 5.51%
573,439 $6.01 Million
Q2 2022

Aug 12, 2022

BUY
$7.31 - $11.85 $2.16 Million - $3.51 Million
295,783 Added 95.07%
606,893 $5.87 Million
Q1 2022

May 13, 2022

BUY
$7.35 - $10.63 $47,451 - $68,627
6,456 Added 2.12%
311,110 $2.56 Million
Q4 2021

Feb 11, 2022

BUY
$4.19 - $9.56 $83,339 - $190,148
19,890 Added 6.98%
304,654 $2.91 Million
Q3 2021

Nov 12, 2021

BUY
$3.56 - $4.64 $256 - $334
72 Added 0.03%
284,764 $1.32 Million
Q2 2021

Aug 13, 2021

SELL
$3.95 - $5.41 $817,334 - $1.12 Million
-206,920 Reduced 42.09%
284,692 $1.23 Million
Q1 2021

May 12, 2021

BUY
$4.52 - $7.8 $231,979 - $400,319
51,323 Added 11.66%
491,612 $2.6 Million
Q4 2020

Feb 12, 2021

BUY
$4.37 - $9.46 $73,507 - $159,126
16,821 Added 3.97%
440,289 $3.1 Million
Q3 2020

Nov 13, 2020

SELL
$8.56 - $26.93 $42,466 - $133,599
-4,961 Reduced 1.16%
423,468 $3.84 Million
Q2 2020

Aug 13, 2020

BUY
$21.21 - $31.55 $754,673 - $1.12 Million
35,581 Added 9.06%
428,429 $11.8 Million
Q1 2020

May 14, 2020

BUY
$18.43 - $38.04 $553,563 - $1.14 Million
30,036 Added 8.28%
392,848 $8.64 Million
Q4 2019

Feb 13, 2020

BUY
$29.6 - $43.71 $316,364 - $467,172
10,688 Added 3.04%
362,812 $13.7 Million
Q3 2019

Nov 12, 2019

BUY
$29.87 - $42.22 $388,190 - $548,691
12,996 Added 3.83%
352,124 $10.9 Million
Q2 2019

Aug 14, 2019

BUY
$31.16 - $39.46 $3.25 Million - $4.11 Million
104,193 Added 44.35%
339,128 $13.4 Million
Q1 2019

May 14, 2019

BUY
$19.96 - $38.62 $918,359 - $1.78 Million
46,010 Added 24.35%
234,935 $9.07 Million
Q4 2018

Feb 13, 2019

BUY
$23.57 - $32.33 $347,445 - $476,576
14,741 Added 8.46%
188,925 $4.45 Million
Q3 2018

Nov 13, 2018

BUY
$22.5 - $39.35 $3.92 Million - $6.85 Million
174,184 New
174,184 $5.32 Million

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.